The phenotype of CD44+/CD24− in ovarian cancer cells has been reported to exhibit CSC-like properties of enhanced differentiation, invasion, and resistance to chemotherapy [28,29], while CD44+/CD24+/Epcam+ exhibited stem cell characteristics in other reports [30]. This evidence concerns the gene CD44 and ovarian cancer.